RYLEVO Trademark

Trademark Overview

On Monday, April 23, 2012, a trademark application was filed for RYLEVO with the United States Patent and Trademark Office. The USPTO has given the RYLEVO trademark a serial number of 85605397. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, November 16, 2015. This trademark is owned by Glaxo Group Limited. The RYLEVO trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines
rylevo

General Information

Serial Number85605397
Word MarkRYLEVO
Filing DateMonday, April 23, 2012
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, November 16, 2015
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 21, 2012

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, April 30, 2012
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBrentford, Middlesex TW89GS
GB
Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressGreenford, Middlesex UB60NN
GB

Trademark Events

Event DateEvent Description
Tuesday, December 1, 2015PETITION TO DIRECTOR DENIED
Monday, November 16, 2015ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, November 16, 2015ABANDONMENT - NO USE STATEMENT FILED
Friday, October 23, 2015PETITION INQUIRY LETTER ISSUED
Wednesday, October 21, 2015ASSIGNED TO PETITION STAFF
Tuesday, September 15, 2015PETITION TO DIRECTOR - CHANGE BASIS - RECEIVED
Tuesday, September 15, 2015TEAS DELETE 1(B) BASIS RECEIVED
Tuesday, June 23, 2015TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, April 2, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, April 1, 2015EXTENSION 5 GRANTED
Thursday, March 26, 2015EXTENSION 5 FILED
Thursday, March 26, 2015TEAS EXTENSION RECEIVED
Saturday, October 4, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, October 3, 2014EXTENSION 4 GRANTED
Tuesday, September 30, 2014EXTENSION 4 FILED
Tuesday, September 30, 2014TEAS EXTENSION RECEIVED
Saturday, April 5, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, April 4, 2014EXTENSION 3 GRANTED
Tuesday, April 1, 2014EXTENSION 3 FILED
Tuesday, April 1, 2014TEAS EXTENSION RECEIVED
Wednesday, October 30, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, October 29, 2013EXTENSION 2 GRANTED
Wednesday, September 25, 2013EXTENSION 2 FILED
Friday, October 25, 2013CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, September 25, 2013TEAS EXTENSION RECEIVED
Friday, April 5, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, April 3, 2013EXTENSION 1 GRANTED
Wednesday, April 3, 2013EXTENSION 1 FILED
Wednesday, April 3, 2013TEAS EXTENSION RECEIVED
Monday, March 25, 2013APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, March 25, 2013TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, March 25, 2013ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, March 25, 2013TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, October 16, 2012NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, August 21, 2012OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 21, 2012PUBLISHED FOR OPPOSITION
Wednesday, August 1, 2012NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, July 12, 2012APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, July 11, 2012ASSIGNED TO EXAMINER
Monday, April 30, 2012NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, April 26, 2012NEW APPLICATION ENTERED IN TRAM

Related Keywords

rylevo pharmaceutical treatment disorders preparations substances diseases ophthalmic respiratory hepatological oncological